Skip to main content
๐ŸงฌPeptide Protocol Wiki

Neuropeptide Y: Dosing Protocols

Dosing guidelines, reconstitution, and administration information

โœ“Reviewed byDr. Research Team(MD (composite credential representing medical review team), PhD in Pharmacology)
๐Ÿ“…Updated February 12, 2026
Verified

๐Ÿ“ŒTL;DR

  • โ€ข1 dosing protocols documented
  • โ€ขReconstitution instructions included
  • โ€ขStorage: Store lyophilized NPY at -20 degrees C, protected from light and moisture. Reconstituted solutions should be used promptly or stored refrigerated at 2-8 degrees C for short-term use.

Protocol Quick-Reference

PTSD and depression research

Dosing

Amount

6.8 mg

Frequency

Single dose

Duration

Single administration

Administration

Route

Intranasal

Timing

Delivered via nasal atomizer device; intranasal route bypasses blood-brain barrier for direct CNS delivery

Cycle

Duration

Single dose

Repeatable

Yes

โš—๏ธ Suggested Bloodwork (2 tests)

CBC with differential

When: Baseline

Why: Baseline blood cell counts

CMP (Comprehensive Metabolic Panel)

When: Baseline

Why: Baseline metabolic panel

๐Ÿ’ก Key Considerations
  • โ†’Not approved for therapeutic use: all data from early-phase clinical trials
  • โ†’NPY has complex effects on appetite, cardiovascular function, and stress response; systemic administration may have unintended effects
  • โ†’Intranasal delivery is required for CNS effects as NPY does not efficiently cross the blood-brain barrier systemically

Unlock dosing protocols

Free access to research-backed dosing information for all peptides.

150+ peptide profiles ยท 30+ comparisons ยท 18 research tools

Already subscribed?
PurposeDoseFrequencyDurationNotes
Intranasal NPY for Major Depression (Sayed et al., 2020)6.8 mg intranasal insufflationSingle doseSingle administrationRandomized controlled trial in MDD patients on stable antidepressants. Effects assessed up to 48 hours post-dose. Preliminary antidepressant effects observed.

Unlock full dosage protocols

Free access to complete dosing tables and protocol details.

150+ peptide profiles ยท 30+ comparisons ยท 18 research tools

Already subscribed?
Dosing protocol timeline for Neuropeptide Y
Visual guide to dosing schedules and timing
Administration guide for Neuropeptide Y
Step-by-step reconstitution and administration instructions

๐Ÿ’‰Reconstitution Instructions

Clinical trial formulations used NPY dissolved in saline for intranasal insufflation via atomizer device. Research-grade NPY should be reconstituted in sterile saline or PBS.

Recommended Injection Sites

  • โœ“Intranasal (clinical trials)
  • โœ“Intracerebroventricular (animal research)
  • โœ“Intravenous (research)

๐ŸงŠStorage Requirements

Store lyophilized NPY at -20 degrees C, protected from light and moisture. Reconstituted solutions should be used promptly or stored refrigerated at 2-8 degrees C for short-term use.

Community Dosing Protocols

Compare these clinical doses with what 3+ community members report using.

Based on 3+ community reports

View community protocols
โš ๏ธ

Before You Begin

Review safety warnings and contraindications before starting any protocol.

Important Disclaimer#

Neuropeptide Y is not approved for therapeutic use in any country. All dosing information is derived from early-phase clinical trials and preclinical research. NPY is an endogenous neuropeptide with complex effects on appetite, cardiovascular function, and stress response.

Clinical Trial Dosing#

Intranasal NPY for Depression (Phase 1)#

Sayed et al. (2020) conducted a randomized controlled trial in 30 patients with major depressive disorder who were on stable antidepressant medication. Patients received a single intranasal dose of 6.8 mg NPY or placebo via nasal insufflation. Effects were assessed at baseline, +1 hour, +5 hours, +24 hours, and +48 hours after administration.

Intranasal Delivery Rationale#

Intranasal administration bypasses the blood-brain barrier via olfactory and trigeminal nerve pathways, allowing direct CNS delivery. NPY has poor BBB penetration when administered systemically, making intranasal delivery essential for achieving therapeutic brain concentrations.

Route of Administration#

Clinical trials have exclusively used intranasal delivery for CNS applications. Preclinical studies have used intracerebroventricular (ICV) injection for direct brain delivery in animal models.

Reconstitution Instructions#

Clinical trial formulations dissolved NPY in sterile saline for delivery via nasal atomizer device. Research-grade lyophilized NPY should be reconstituted in sterile water or PBS.

Storage Guidelines#

Store lyophilized NPY at -20 degrees C. Reconstituted solutions should be used promptly due to potential degradation by endogenous peptidases.

Dosing Context#

Neuropeptide Y belongs to the Neuropeptide category of research peptides. Dosing protocols for Neuropeptide Y are derived from available clinical trial data. These protocols are provided for research reference only and do not constitute medical advice. Actual dosing decisions should be made by qualified healthcare providers based on individual patient factors.

Research Protocols#

The following dosing protocols have been documented in clinical research for Neuropeptide Y:

Intranasal NPY for Major Depression (Sayed et al., 2020)#

Dose: 6.8 mg intranasal insufflation

Frequency: Single dose

Duration: Single administration

Randomized controlled trial in MDD patients on stable antidepressants. Effects assessed up to 48 hours post-dose. Preliminary antidepressant effects observed.

Reconstitution and Preparation#

Clinical trial formulations used NPY dissolved in saline for intranasal insufflation via atomizer device. Research-grade NPY should be reconstituted in sterile saline or PBS.

Injection Sites#

Recommended injection sites for Neuropeptide Y include:

  • Intranasal (clinical trials)
  • Intracerebroventricular (animal research)
  • Intravenous (research)

Site rotation is recommended to minimize local tissue reactions and ensure consistent absorption.

Storage Requirements#

Store lyophilized NPY at -20 degrees C, protected from light and moisture. Reconstituted solutions should be used promptly or stored refrigerated at 2-8 degrees C for short-term use.

Subscribe to see vendor options

Free access to verified vendor scores, pricing, and suppliers.

150+ peptide profiles ยท 30+ comparisons ยท 18 research tools

Already subscribed?

Protocol updates

Get notified when we update dosing protocols or publish related comparisons.

Frequently Asked Questions About Neuropeptide Y

Explore Further

โš ๏ธ

Medical Disclaimer

This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.